15-04-2026 16:22 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Peer Comparison
Cipla Ltd.
 
Peer CompaniesPrice(Rs)Chg(Rs) Chg(%)EPS(Rs.)TTM P/EVolume(000's)1Year Return(%)
Neuland Laboratories 15029.1 490.6 3.37 138.99 108.13 272518.76
Abbott India 25969.8 243.95 0.95 717.26 36.21 1008-16.22
Alkem Laboratories 5575 215.4 4.02 183.49 30.38 257613.2
Divi's Lab 6176.65 104.65 1.72 94.85 65.1 55277.75
NGL Fine-Chem 2329 87.05 3.88 48.17 48.35 756119.72
Sanofi Cons. Health 4699.6 72.5 1.57 104.25 45.08 383-5.15
Glenmark Pharma 2260.15 66.1 3.01 0.74 3057.16 2620164.33
Pfizer 4914.25 64.45 1.33 186.58 26.34 60517.23
Caplin Point Lab 1738.55 52.35 3.1 47.66 36.48 3599-9.79
Eris Lifesciences 1440.3 52.25 3.76 20.44 70.48 53734.44
Sanofi India 3517.7 52.2 1.51 141.85 24.8 2454-43.21
Windlas Biotech 863.65 50.75 6.24 31.6 27.33 2245-19.32
Kwality Pharma 1547.4 48.35 3.23 54.5 28.39 2823988.98
Innova Captab 734 44 6.38 13.92 52.73 2585-18.09
Gland Pharma 1765 43.3 2.51 70.96 24.87 204623.72
Sun Pharma Inds. 1695 43 2.6 16.77 101.07 119382-0.6
Mankind Pharma 2120 40.65 1.95 41.27 51.37 12457-12.68
RPG Life Sciences 1922 39.5 2.1 122.51 15.69 399-11.88
Aurobindo Pharma 1375.5 35.85 2.68 36.69 37.49 2989421.17
Lupin 2342.5 30.15 1.3 120.18 19.49 1700016.42
Page 1 of 9
Prev || Next
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.